Latest P53 Stories
Unique delivery vehicle to be developed across p53 mutated solid tumors by delivering wild type p21 NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ -- SELLAS Life Sciences
Research Presented at the Society of Gynecologic Oncology 2015 Annual Meeting Suggest Treatment Options Based on Biomarker Profile May Result in Improved Outcomes IRVING, Texas, March
Study Results Highlight Molecular Similarities and Differences between Uterine Papillary and Ovarian Serous Carcinomas, and between Epithelial Ovarian and Endometrial Cancers IRVING,
Study Using Caris Molecular Intelligence's Multiplatform Profiling Service Highlighted in Plenary Session at Society of Surgical Oncology Symposium IRVING, Texas, March 27, 2015 /PRNewswire/
Georgia State University has signed a license agreement with Cisen Pharmaceutical Co.
Norway's premier charitable organization awards Israel cancer geneticist International Research Award for work on cell survival and DNA stability NEW YORK, Jan.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Elucidating Disease Biology and Identifying Potential Treatment Options
UC Davis researchers have uncovered a complex interaction between the proteins Rbm38 and p53 that governs tumor suppression and aging Sacramento, Calif.